| Literature DB >> 31508527 |
Rajinder Raina1, Pawan K Verma1, Rajinder Peshin2, Harpreet Kour1.
Abstract
Plants have been used for thousands of years as medicine for treating variety of diseases and medical complaints by most of the civilizations. Juniperus communis L. is an evergreen aromatic shrub with high therapeutic potential for the treatment of diseases in human and animals. The plant is rich in aromatic oils, invert sugars, resins, catechin, organic acid, terpenic acids, leucoanthocyanidin, alkaloids, flavonoids, tannins, gums, lignins, wax, etc. Juniper berries or extract of the plant has traditionally been used as diuretic, anti-arthritis, anti-diabetes, antiseptic as well as for the treatment of gastrointestinal and autoimmune disorders. The essential oil and extracts of juniper have been experimentally documented to have antioxidant, antibacterial, antiviral and antifungal activities. Recent studies have also found anti-inflammatory, cytotoxic, hypoglycemic and hypolipidemic effects of berries in experimental models. Further, the essential oil incorporation retarded lipid peroxidation in preserved meat due to its high antioxidant effect which not only improved meat product quality but also improved shelf life of the product. Thus natural antioxidant such as juniper can be used in place synthetic antioxidant for the preservation and improving self-life of meat products. New well designed clinical trials in human and animals using well-characterized J. communis extract or oil need to be conducted so that additional information is generated which can support the use of this natural product as a nutraceutical.Entities:
Keywords: Anti-proliferative; Antioxidant; Chemistry; Food science; Juniperus communis; Nutraceutical; Phytochemical ingredients
Year: 2019 PMID: 31508527 PMCID: PMC6726717 DOI: 10.1016/j.heliyon.2019.e02376
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
In-vitro cytotoxicity of J. communis L or Its Active Constituents in Experimental Models.
| Fraction/Active constituent | Experimental model | Cytotoxic effect | Reference |
|---|---|---|---|
| Aqueous berry extract | MCF-7/AZ mammary carcinoma cells | The anti-proliferative effect due to inhibition of cellular receptor tyrosine kinases, insulin-like growth factor receptors (IGF-1R) and C-erbB2/HER2/neu receptors | |
| Berry extract | Human neuroblastoma SH-SY 5Y cells | Activated cellular relocalization of p53 and DNA fragmentation dependent cell death by induction of p53 associated apoptosis through the potentiation and synergism by several plant phenolics | |
| Ethyl acetate fraction of | Cell viability assay on HepG2 cells | Fraction in WST-1 proliferation assay didn't affect HepG2 cell viability after treatment for 24 h at a concentration between 0-10 μg/ml | |
| Extract of areal part of | In-vitro assay on Human prostate cancer cells (PC-3), Human colon cancer cells (HCT-116) and mammary cancer cells (MCF-7) using MTT | Highest activity with the safest margin observed for the total methanolic extract against human breast cancer cell line (MCF-7) | |
| Diterpenes isocupressic and aryltetralin lignan deoxypodophyllotoxin from | Malignant – MB231 breast cancer cells | Induced caspase dependent programmed cell death (apoptosis); aryltetralin lignan deoxypodophyllotoxin inhibited cell survival pathways mediated by the MAPK/ERK and NK-kß signaling pathways within hours of treatment | |
| Imbricatolic acid isolated from methanolic extract of ripe berries | p53 null CaLu-6 cells | Induced up-regulation of cyclic dependent kinase inhibitors and their accumulation in G1 phase of the cell cycle and also degradation of cyclines A, D1 and E | |
| Methanolic and aqueous berry extract | Colorectal cancer cell line CaCO2 and HeLa cervical cancer cell line | Block the proliferation of cells in both cell lines with IC50 between 500-2500 μg/ml |